AGÕæÈ˹ٷ½

STOCK TITAN

[Form 4] Qualys, Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

American Express Co. (AXP) filed a Form 144 indicating a planned sale of 61,721 common shares through Morgan Stanley Smith Barney on or about 5 Aug 2025. At the filing date’s implied price (â‰� $297/share), the transaction is valued at $18.36 million. The shares represent roughly 0.009 % of AXP’s 695.9 million shares outstanding, suggesting limited dilution or ownership impact.

The filer—whose name is redacted in the excerpt—will dispose of stock acquired primarily via restricted-stock vesting between 2016-2025 under company plans; no prior sales were reported in the last three months. Because the notice affirms the absence of undisclosed adverse information and may be part of a 10b5-1 plan, the event appears routine insider diversification rather than a signal on fundamentals.

American Express Co. (AXP) ha presentato un modulo Form 144 segnalando una vendita pianificata di 61.721 azioni ordinarie tramite Morgan Stanley Smith Barney intorno al 5 agosto 2025. Al prezzo implicito alla data della presentazione (circa 297 $/azione), l’operazione ha un valore di 18,36 milioni di dollari. Le azioni rappresentano circa lo 0,009% delle 695,9 milioni di azioni in circolazione di AXP, indicando un impatto limitato su diluizione o proprietà.

Il soggetto che effettua la vendita � il cui nome è oscurato nell’estratto � cederà titoli acquisiti principalmente tramite vesting di azioni vincolate tra il 2016 e il 2025 nell’ambito di piani aziendali; non sono state segnalate vendite precedenti negli ultimi tre mesi. Poiché la notifica conferma l’assenza di informazioni negative non divulgate e può far parte di un piano 10b5-1, l’evento sembra una normale diversificazione interna piuttosto che un segnale sui fondamentali.

American Express Co. (AXP) presentó un Formulario 144 indicando una venta planificada de 61,721 acciones ordinarias a través de Morgan Stanley Smith Barney alrededor del 5 de agosto de 2025. Al precio implícito en la fecha de presentación (aproximadamente $297 por acción), la transacción tiene un valor de $18.36 millones. Las acciones representan aproximadamente el 0.009 % de las 695.9 millones de acciones en circulación de AXP, lo que sugiere un impacto limitado en la dilución o la propiedad.

El declarante � cuyo nombre está redactado en el extracto � venderá acciones adquiridas principalmente mediante adquisición restringida de acciones entre 2016 y 2025 bajo planes de la empresa; no se reportaron ventas previas en los últimos tres meses. Dado que el aviso confirma la ausencia de información adversa no divulgada y puede formar parte de un plan 10b5-1, el evento parece una diversificación rutinaria de un insider más que una señal sobre los fundamentos.

American Express Co. (AXP)ëŠ� Morgan Stanley Smith Barneyë¥� 통해 61,721ì£� 보통ì£� ë§¤ê° ê³„íšì� 2025ë…� 8ì›� 5ì¼ê²½ì—� 제출하는 Form 144ë¥� 제출했습니다. 제출ì� 기준 암시 ê°€ê²�(ì•� 297달러/ì£�)으로 거래 가치는 1,836ë§� 달러ì—� 달합니다. ì� 주ì‹ì€ AXPì� ì´� 6ì–� 9,590ë§� ì£� ì¤� ì•� 0.009%ì—� 해당하여 í¬ì„ì´ë‚˜ 소유ê¶� ì˜í–¥ì� 제한ì ìž„ì� 시사합니ë‹�.

제출ìžëŠ”(ì´ë¦„ì€ ë°œì·Œë¬¸ì—ì„� ì‚­ì œë�) 주로 2016ë…„ë¶€í„� 2025년까지 회사 계íšì—� ë”°ë¼ ì œí•œì£¼ì‹ ì·¨ë“ì� 통해 íšë“í•� 주ì‹ì� 처분í•� 예정ì´ë©°, 최근 3개월 ë‚´ì— ë³´ê³ ë� ì´ì „ 매ê°ì€ 없습니다. ì� 통지ëŠ� 미공ê°� ë¶€ì � ì •ë³´ê°€ ì—†ìŒì� 확ì¸í•˜ë©° 10b5-1 계íšì� ì¼ë¶€ì� ìˆ� 있으므ë¡�, ì´ë²ˆ ì‚¬ê±´ì€ ê¸°ë³¸ì � 사항ì—� 대í•� 신호ë¼ê¸°ë³´ë‹¤ ë‚´ë¶€ìžì˜ ì¼ìƒì ì¸ ìžì‚° 다ê°í™”로 보입니다.

American Express Co. (AXP) a déposé un formulaire 144 indiquant une vente prévue de 61 721 actions ordinaires via Morgan Stanley Smith Barney aux alentours du 5 août 2025. Au prix implicite à la date de dépôt (environ 297 $/action), la transaction est valorisée à 18,36 millions de dollars. Ces actions représentent environ 0,009 % des 695,9 millions d’actions en circulation d’AXP, suggérant un impact limité sur la dilution ou la propriété.

Le déclarant � dont le nom est masqué dans l’extrait � cédera des titres acquis principalement par attribution d’actions restreintes entre 2016 et 2025 dans le cadre de plans d’entreprise ; aucune vente antérieure n’a été signalée au cours des trois derniers mois. Comme l’avis confirme l’absence d’informations défavorables non divulguées et peut faire partie d’un plan 10b5-1, l’opération semble être une diversification interne de routine plutôt qu’un signal sur les fondamentaux.

American Express Co. (AXP) hat ein Formular 144 eingereicht, das einen geplanten Verkauf von 61.721 Stammaktien über Morgan Stanley Smith Barney am oder um den 5. August 2025 anzeigt. Zum am Einreichungsdatum implizierten Kurs (ca. 297 $/Aktie) beläuft sich der Wert der Transaktion auf 18,36 Millionen US-Dollar. Die Aktien entsprechen etwa 0,009 % der 695,9 Millionen ausstehenden AXP-Aktien, was auf eine begrenzte Verwässerung oder Eigentumsauswirkung hinweist.

Der Einreicher � dessen Name im Auszug geschwärzt ist � wird Aktien veräußern, die hauptsächlich durch Restricted-Stock-Vesting zwischen 2016 und 2025 im Rahmen von Unternehmensplänen erworben wurden; in den letzten drei Monaten wurden keine vorherigen Verkäufe gemeldet. Da die Mitteilung das Fehlen nicht offengelegter negativer Informationen bestätigt und Teil eines 10b5-1-Plans sein kann, erscheint das Ereignis eher als routinemäßige Insider-Diversifikation denn als Signal für die Fundamentaldaten.

Positive
  • Minimal ownership impact: 61,721 shares equal only ~0.009 % of outstanding shares, limiting dilution concerns.
Negative
  • Insider selling of $18.4 m may be perceived as a modest bearish signal despite likely diversification motives.

Insights

TL;DR: $18 m insider sale (~0.009 % float) is immaterial and likely routine.

The proposed Rule 144 trade amounts to fewer than 62 k shares against a 696 m share base, so liquidity impact is negligible. Insider disposals can flag sentiment, but this filing cites vesting from long-term compensation and no recent sales, consistent with portfolio rebalancing. Absent concurrent negative news, market reaction should be muted. Monitoring future filings will confirm whether this is an isolated sale or part of a larger exit.

American Express Co. (AXP) ha presentato un modulo Form 144 segnalando una vendita pianificata di 61.721 azioni ordinarie tramite Morgan Stanley Smith Barney intorno al 5 agosto 2025. Al prezzo implicito alla data della presentazione (circa 297 $/azione), l’operazione ha un valore di 18,36 milioni di dollari. Le azioni rappresentano circa lo 0,009% delle 695,9 milioni di azioni in circolazione di AXP, indicando un impatto limitato su diluizione o proprietà.

Il soggetto che effettua la vendita � il cui nome è oscurato nell’estratto � cederà titoli acquisiti principalmente tramite vesting di azioni vincolate tra il 2016 e il 2025 nell’ambito di piani aziendali; non sono state segnalate vendite precedenti negli ultimi tre mesi. Poiché la notifica conferma l’assenza di informazioni negative non divulgate e può far parte di un piano 10b5-1, l’evento sembra una normale diversificazione interna piuttosto che un segnale sui fondamentali.

American Express Co. (AXP) presentó un Formulario 144 indicando una venta planificada de 61,721 acciones ordinarias a través de Morgan Stanley Smith Barney alrededor del 5 de agosto de 2025. Al precio implícito en la fecha de presentación (aproximadamente $297 por acción), la transacción tiene un valor de $18.36 millones. Las acciones representan aproximadamente el 0.009 % de las 695.9 millones de acciones en circulación de AXP, lo que sugiere un impacto limitado en la dilución o la propiedad.

El declarante � cuyo nombre está redactado en el extracto � venderá acciones adquiridas principalmente mediante adquisición restringida de acciones entre 2016 y 2025 bajo planes de la empresa; no se reportaron ventas previas en los últimos tres meses. Dado que el aviso confirma la ausencia de información adversa no divulgada y puede formar parte de un plan 10b5-1, el evento parece una diversificación rutinaria de un insider más que una señal sobre los fundamentos.

American Express Co. (AXP)ëŠ� Morgan Stanley Smith Barneyë¥� 통해 61,721ì£� 보통ì£� ë§¤ê° ê³„íšì� 2025ë…� 8ì›� 5ì¼ê²½ì—� 제출하는 Form 144ë¥� 제출했습니다. 제출ì� 기준 암시 ê°€ê²�(ì•� 297달러/ì£�)으로 거래 가치는 1,836ë§� 달러ì—� 달합니다. ì� 주ì‹ì€ AXPì� ì´� 6ì–� 9,590ë§� ì£� ì¤� ì•� 0.009%ì—� 해당하여 í¬ì„ì´ë‚˜ 소유ê¶� ì˜í–¥ì� 제한ì ìž„ì� 시사합니ë‹�.

제출ìžëŠ”(ì´ë¦„ì€ ë°œì·Œë¬¸ì—ì„� ì‚­ì œë�) 주로 2016ë…„ë¶€í„� 2025년까지 회사 계íšì—� ë”°ë¼ ì œí•œì£¼ì‹ ì·¨ë“ì� 통해 íšë“í•� 주ì‹ì� 처분í•� 예정ì´ë©°, 최근 3개월 ë‚´ì— ë³´ê³ ë� ì´ì „ 매ê°ì€ 없습니다. ì� 통지ëŠ� 미공ê°� ë¶€ì � ì •ë³´ê°€ ì—†ìŒì� 확ì¸í•˜ë©° 10b5-1 계íšì� ì¼ë¶€ì� ìˆ� 있으므ë¡�, ì´ë²ˆ ì‚¬ê±´ì€ ê¸°ë³¸ì � 사항ì—� 대í•� 신호ë¼ê¸°ë³´ë‹¤ ë‚´ë¶€ìžì˜ ì¼ìƒì ì¸ ìžì‚° 다ê°í™”로 보입니다.

American Express Co. (AXP) a déposé un formulaire 144 indiquant une vente prévue de 61 721 actions ordinaires via Morgan Stanley Smith Barney aux alentours du 5 août 2025. Au prix implicite à la date de dépôt (environ 297 $/action), la transaction est valorisée à 18,36 millions de dollars. Ces actions représentent environ 0,009 % des 695,9 millions d’actions en circulation d’AXP, suggérant un impact limité sur la dilution ou la propriété.

Le déclarant � dont le nom est masqué dans l’extrait � cédera des titres acquis principalement par attribution d’actions restreintes entre 2016 et 2025 dans le cadre de plans d’entreprise ; aucune vente antérieure n’a été signalée au cours des trois derniers mois. Comme l’avis confirme l’absence d’informations défavorables non divulguées et peut faire partie d’un plan 10b5-1, l’opération semble être une diversification interne de routine plutôt qu’un signal sur les fondamentaux.

American Express Co. (AXP) hat ein Formular 144 eingereicht, das einen geplanten Verkauf von 61.721 Stammaktien über Morgan Stanley Smith Barney am oder um den 5. August 2025 anzeigt. Zum am Einreichungsdatum implizierten Kurs (ca. 297 $/Aktie) beläuft sich der Wert der Transaktion auf 18,36 Millionen US-Dollar. Die Aktien entsprechen etwa 0,009 % der 695,9 Millionen ausstehenden AXP-Aktien, was auf eine begrenzte Verwässerung oder Eigentumsauswirkung hinweist.

Der Einreicher � dessen Name im Auszug geschwärzt ist � wird Aktien veräußern, die hauptsächlich durch Restricted-Stock-Vesting zwischen 2016 und 2025 im Rahmen von Unternehmensplänen erworben wurden; in den letzten drei Monaten wurden keine vorherigen Verkäufe gemeldet. Da die Mitteilung das Fehlen nicht offengelegter negativer Informationen bestätigt und Teil eines 10b5-1-Plans sein kann, erscheint das Ereignis eher als routinemäßige Insider-Diversifikation denn als Signal für die Fundamentaldaten.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
POSEY BRUCE K

(Last) (First) (Middle)
C/O QUALYS, INC.
919 E. HILLSDALE BLVD.

(Street)
FOSTER CITY CA 94404

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
QUALYS, INC. [ QLYS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
CHIEF LEGAL OFFICER
3. Date of Earliest Transaction (Month/Day/Year)
08/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/01/2025 F 2,278(1) D $130.53 58,365 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The reported shares were withheld to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units.
/s/ Bruce K. Posey 08/05/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many American Express (AXP) shares are being sold under this Form 144?

The notice covers 61,721 common shares.

What is the approximate market value of the planned AXP share sale?

Based on the filing, the sale is valued at about $18.36 million.

When is the scheduled sale date for the AXP shares?

The filer plans to sell on or about August 5, 2025.

Which broker will execute the American Express share sale?

Morgan Stanley Smith Barney LLC, Executive Financial Services is listed as broker.

What percentage of AXP’s shares outstanding does this sale represent?

Approximately 0.009 % of the 695,882,227 shares outstanding.

Were any AXP shares sold by this insider in the last three months?

No. The filing states "Nothing to Report" for prior 3-month sales.
Qualys Inc

NASDAQ:QLYS

QLYS Rankings

QLYS Latest News

QLYS Latest SEC Filings

QLYS Stock Data

4.74B
36.10M
0.63%
98.52%
8.12%
Software - Infrastructure
Services-prepackaged Software
United States
FOSTER CITY